Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Esophageal and esophagogastric junction cancers.

× No keyword cloud information.

80 in total

1. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.

Authors: Paul J Speicher; Asvin M Ganapathi; Brian R Englum; Matthew G Hartwig; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal: J Thorac Oncol Date: 2014-08 Impact factor: 15.609

2. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.

Authors: J A Ajani; L Xiao; J A Roth; W L Hofstetter; G Walsh; R Komaki; Z Liao; D C Rice; A A Vaporciyan; D M Maru; J H Lee; M S Bhutani; A Eid; J C Yao; A P Phan; A Halpin; A Suzuki; T Taketa; P F Thall; S G Swisher
Journal: Ann Oncol Date: 2013-08-23 Impact factor: 32.976

3. Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort.

Authors: Elena Elimova; Xuemei Wang; Wei Qiao; Kazuki Sudo; Roopma Wadhwa; Hironori Shiozaki; Yusuke Shimodaira; Venkatram Planjery; Nikolaos Charalampakis; Jeffrey H Lee; Brian R Weston; Manoop S Bhutani; Ritsuko Komaki; David C Rice; Stephen G Swisher; Mariela A Blum; Jane E Rogers; Heath D Skinner; Dipen M Maru; Wayne L Hofstetter; Jaffer A Ajani
Journal: Oncology Date: 2018-04-27 Impact factor: 2.935

4. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.

Authors: Arianna Barbetta; Francisco Schlottmann; Tamar Nobel; David B Sewell; Meier Hsu; Kay See Tan; Hans Gerdes; Pari Shah; Manjit S Bains; Matthew Bott; James M Isbell; David R Jones; Daniela Molena
Journal: Ann Thorac Surg Date: 2018-04-05 Impact factor: 4.330

Review 5. Endoscopic options for early stage esophageal cancer.

Authors: Pari M Shah; Hans Gerdes
Journal: J Gastrointest Oncol Date: 2015-02

6. Use of endoscopic ultrasound-based techniques in tumor of the guts and beyond.

Authors: Chu Pei; Guangqiao Zeng
Journal: Chin J Cancer Res Date: 2014-12 Impact factor: 5.087

7. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.

Authors: J A Ajani; X Wang; S Song; A Suzuki; T Taketa; K Sudo; R Wadhwa; W L Hofstetter; R Komaki; D M Maru; J H Lee; M S Bhutani; B Weston; V Baladandayuthapani; Y Yao; S Honjo; A W Scott; H D Skinner; R L Johnson; D Berry
Journal: Mol Oncol Date: 2013-10-28 Impact factor: 6.603

8. Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.

Authors: Fausto Petrelli; Michele Ghidini; Sandro Barni; Giovanni Sgroi; Rodolfo Passalacqua; Gianluca Tomasello
Journal: Gastric Cancer Date: 2018-11-27 Impact factor: 7.370

9. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort.

Authors: N K S Cheedella; A Suzuki; L Xiao; W L Hofstetter; D M Maru; T Taketa; K Sudo; M A Blum; S H Lin; J Welch; J H Lee; M S Bhutani; D C Rice; A A Vaporciyan; S G Swisher; J A Ajani
Journal: Ann Oncol Date: 2012-12-17 Impact factor: 32.976

10. The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis.

Authors: Jeremiah T Martin; Mathias Worni; Joseph B Zwischenberger; Beat Gloor; Ricardo Pietrobon; Thomas A D'Amico; Mark F Berry
Journal: Ann Thorac Surg Date: 2012-10-11 Impact factor: 4.330